查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301122

缓释辅料的市场规模、份额和趋势分析报告：2023-2030 年按给药途径、技术、产品、地区和细分市场划分的趋势

Sustained Release Excipients Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Transdermal), By Technology (Transdermal, Implants), By Product (Gelatin, Sugars), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

缓释辅料市场增长和趋势

GrandView Research, Inc.最新报告显示，2023年至2030年，全球缓释辅料市场规模将以8.4%的复合年增长率扩张，2030年将达到23.6亿美元。预计达到100万美元。

缓释辅料市场的增长归因于缓释药物需求的增加、患者依从率的提高以及这种给药方法相对于传统方法的多重优势。 这些赋形剂通常用作胶囊或片剂以提供药物的缓慢释放。 这缩短了药物剂量之间的间隔，这比立即释放製剂具有优势。 赋形剂的崩解、溶解和降解导致药物持续释放。

控释给药系统的优点包括减少给药频率、提高患者依从性、恆定血浆药物浓度、降低过量毒性发生率以及提高长期成本效益。这是使用控释药物递送系统的一些主要优点 经常使用传统口服药物通常会导致不良症状，例如胃肠道不适、痉挛、噁心和腹泻。 缓释药物製剂的使用可以缓解患者的这些症状，并使他们能够维持体内所需的治疗药物水平。 此外，他们正在增加缓释製剂的采用，从而提高患者的依从性并提高治疗效果。

过去几年，全球范围内的抗生素耐药性有所增加。 传统製剂的滥用和误用已被确定为抗生素耐药性的主要原因。 在某些情况下，患者在给药后几天内康復并停止推荐剂量的药物。 这种抵抗导致医疗费用增加、住院时间延长和死亡率增加。 传染病和慢性病的增加也导致了抗生素耐药性，这对传统剂型市场产生了不利影响。 因此，正在引入替代方法来治疗和控制这些疾病。

控释製剂被医生广泛接受，用于预防抗生素耐药性。 这些製剂在血浆中产生良好的治疗药物水平并降低给药频率，使其成为医生的理想选择，并增加了行业的需求。 由于 COVID-19 大流行，一些国家实施封锁和运输/旅行禁令，对药品生产的干扰以及对辅料需求的影响将是相对短期的。 然而，各国长期封锁导致的供应中断可能会对固体口服药物的生产产生重大影响。

这反过来将对全球辅料需求的增长产生重大影响。 欧洲，包括法国、西班牙和意大利，行业增长空间很大。 这是由于这些国家越来越多地采用先进药物。 此外，欧洲药品管理局（EMA）和药品及保健品监管局（MHRA）等监管机构正在不断努力，以确保该地区的高安全标准和易于获得低成本药品。 高可支配收入、先进的医疗基础设施和不断增加的产品批准预计将为欧洲创造增长机会。

市场主要参与者不断推出新产品，以满足製药行业不断变化的消费者需求。 例如，2022年11月，Roquette Freres宣布推出Pearitol CR-H，该产品增强了压缩製剂中药物的持续释放。 该产品将进一步提升压片工艺，提高竞争力。

缓释辅料市场报告亮点

  • 聚合物产品细分市场将在 2022 年占据最大份额 聚合物在缓释製剂中的多样化应用预计将推动行业增长
  • 传统的口服给药途径促进了该细分市场的快速增长存储、预给药、便携性和非侵入性等便利性是推动透皮给药途径采用的主要因素。
  • 透皮贴剂的日益普及促进了该细分市场的快速增长。
  • 由于许多行业参与者都拥有强大的产品组合，2022 年靶向给药将占销售额的最大份额。 植入式缓释药物输送系统具有效率高、副作用少、便利性高等优点，正在推动该领域的发展。
  • 由于在研发方面的高投入以及先进技术的可用性，北美将在 2022 年主导全球行业
  • 由于印度和中国等新兴经济体的製药业不断发展，亚太地区预计在预测期内将创下最快的复合年增长率。
  • 主要市场参与者包括 Roquette Freres、BASF、International Flavors & Fragrances, Inc.、Ashland、Evonik Industries AG、Croda International Plc 和 Gattefosse。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 段定义
  • 区域范围
  • 估计/预测时间表
  • 目的
  • 调查方法
  • 信息获取
    • 购买的数据库
    • Gvr 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场形成和验证
  • 型号详细信息
    • 产品流分析
  • 辅助信息列表
  • 缩写列表

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第三章市场变量、趋势和范围

  • 市场细分和范围
  • 市场体系展望
    • 母公司市场前景
    • 相关/辅助市场前景
  • 市场趋势和展望
  • 市场动态
    • 与传统剂型相比，益处更多
    • 儿童和老年人对缓释剂型的需求
    • 抗生素耐药性
  • 市场製约因素分析
    • 剂量倾卸引起的药物毒性
    • 需要高剂量 API
  • 商业环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19 感染的影响分析
  • 市场机遇与挑战分析

第四章产品业务分析

  • 缓释辅料市场：产品变异分析
  • 明胶
  • 聚合物
  • 矿物质
  • 糖
  • 酒精
  • 壳聚醣

第 5 章技术业务分析

  • 缓释辅料市场：技术波动分析
  • 有针对性的交付
  • 微胶囊化
  • 沃斯特法
  • 透皮
  • 植入物
  • 凝聚
  • 其他

第 6 章管理途径业务分析

  • 缓释辅料市场：给药途径变化分析
  • 口头
  • 肌肉注射
  • 皮下注射
  • 透皮
  • 阴道
  • 眼科
  • 静脉注射
  • 其他

第七章区域业务分析

  • 2022 年和 2030 年按地区划分的缓释辅料市场份额
  • 北美
    • SWOT分析
    • 北美缓释辅料市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 欧洲缓释辅料市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 2018-2030 年亚太地区缓释辅料市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲缓释辅料市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 缓释辅料市场，2018-2030 年
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 8 章竞争格局

  • 公司分类
  • 战略规划
    • 推出新产品
    • 合作伙伴关係
    • 获取
    • 合作
    • 筹款
  • 2022 年主要参与者的市场份额分析
  • 公司简介
    • BASF SE
    • International Flavors &Fragrances, Inc.
    • Ashland Global
    • Evonik Industries Inc
    • Croda International Plc
    • Gattefosse
    • Merck KGaA
Product Code: GVR-2-68038-575-5

Sustained Release Excipients Market Growth & Trends

The global sustained release excipients market size is expected to reach USD 2.36 billion by 2030, expanding at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the sustained-release excipients market is attributable to the growing demand for sustained-release drugs, the improvement in patient compliance rate, and the multiple advantages of this drug-delivery method over conventional methods. These excipients are usually used as capsules and tablet formulations to release the drug slower; thereby, the drug has to be taken at less frequent intervals making it advantageous over immediate-release formulations. The sustained release of excipients' disintegration, dissolution, or degradation leads to the modified slower drug release.

Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained-release formulations, enabling higher patient compliance and improved therapeutic effect.

Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.

Controlled release formulations have been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice among physicians, increasing their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may substantially impact the oral solid dosage form drug manufacturing.

This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for industry growth in Europe, including France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, sophisticated healthcare infrastructure, and a rise in product approvals are expected to create growth opportunities in Europe.

Key players in the market are introducing new products to continuously meet the changing requirements of consumers in the pharmaceutical industry. For instance, in November 2022, Roquette Freres announced the launch of Pearlitol CR-H, enhancing API's sustained release in compression formulations. It further enhances the tableting process giving it a competitive edge.

Sustained Release Excipients Market Report Highlights

  • Polymers product segment accounted for the largest share in 2022. Varied usage of polymers in sustained-release formulations is anticipated to fuel industry growth
  • Conventional use of the oral delivery route has contributed to the fastest growth of the segment. Convenience, in terms of storage, premeasured doses, portability, and the noninvasive nature of this route are some of the major factors accelerating its adoption
  • The rising adoption of transdermal patches has contributed to the fastest growth of the segment
  • Targeted drug delivery constituted the largest revenue share in 2022, as a large number of industry players have strong product portfolios. Implantable sustained-release drug delivery systems have improved efficiency, lower adverse effects, and higher convenience, which impels segment growth
  • North America dominated the global industry in 2022 owing to the high investments in R&D and the availability of highly sophisticated technologies in the region
  • Asia Pacific is projected to register the fastest CAGR during the forecast period due to the growing pharmaceutical industry in emerging countries, such as India and China
  • A few of the key market players include Roquette Freres, BASF, International Flavors & Fragrances, Inc., Ashland, Evonik Industries AG, Croda International Plc, and Gattefosse

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
      • 1.1.1.2 Technology Segment
      • 1.1.1.3 Route Of Administration Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increased benefits over conventional dosage forms
    • 3.4.2. Necessity of pediatric and geriatric sustained release dosage forms
    • 3.4.3. Antibiotic resistance
  • 3.5. Market Restraint Analysis
    • 3.5.1. Drug toxicity due to dose dumping
    • 3.5.2. Need for high dose of API
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis
  • 3.8. Market Opportubnity and Challenge Analysis

Chapter 4. Product Business Analysis

  • 4.1. Sustained Release Excipients Market: Product Movement Analysis
  • 4.2. Gelatin
    • 4.2.1. Gelatin Market, 2018 - 2030 (USD Million)
  • 4.3. Polymers
    • 4.3.1. Polymers Market, 2018 - 2030 (USD Million)
  • 4.4. Minerals
    • 4.4.1. Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Sugars
    • 4.5.1. Sugars Market, 2018 - 2030 (USD Million)
  • 4.6. Alcohols
    • 4.6.1. Alcohols Market, 2018 - 2030 (USD Million)
  • 4.7. Chitosan
    • 4.7.1. Chitosan Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Sustained Release Excipients Market: Technology Movement Analysis
    • 5.1.1. Targeted Delivery
  • 5.2. Targeted Delivery Market, 2018 - 2030 (USD Million)
    • 5.2.1. Micro Encapsulation
  • 5.3. Micro Encapsulation Market, 2018 - 2030 (USD Million)
    • 5.3.1. Wurster Technique
  • 5.4. Wurster Technique Market, 2018 - 2030 (USD Million)
    • 5.4.1. Transdermal
  • 5.5. Transdermal Market, 2018 - 2030 (USD Million)
    • 5.5.1. Implants
  • 5.6. Implants Market, 2018 - 2030 (USD Million)
    • 5.6.1. Coacervation
  • 5.7. Coacervation Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Sustained Release Excipients Market: Route of Administration Movement Analysis
  • 6.2. Oral
    • 6.2.1. Oral Market, 2018 - 2030 (USD Million)
  • 6.3. Intramuscular
    • 6.3.1. Intramuscular Market, 2018 - 2030 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Subcutaneous Market, 2018 - 2030 (USD Million)
  • 6.5. Transdermal
    • 6.5.1. Transdermal Market, 2018 - 2030 (USD Million)
  • 6.6. Vaginal
    • 6.6.1. Vaginal Market, 2018 - 2030 (USD Million)
  • 6.7. Ophthalmic
    • 6.7.1. Ophthalmic Market, 2018 - 2030 (USD Million)
  • 6.8. Intravenous
    • 6.8.1. Intravenous Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Sustained Release Excipients Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Sustained Release Excipients Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Profiles
    • 8.4.1. BASF SE
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. International Flavors & Fragrances, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Ashland Global
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Evonik Industries Inc
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Croda International Plc
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Gattefosse
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Merck KGaA
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 North America Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Europe Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Europe Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 Germany Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Germany Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 UK Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 UK Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 UK Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 France Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 France Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Italy Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Italy Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Spain Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Spain Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Denmark Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Denmark Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Sweden Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Sweden Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Sweden Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Norway Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Norway Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Norway Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 China Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 China Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 China Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 Japan Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 India Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 India Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 India Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 South Korea Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 South Korea Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Australia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Australia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Australia Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Thailand Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Thailand Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 Thailand Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 70 Latin America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Latin America Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Brazil Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Brazil Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Mexico Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Mexico Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Argentina Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Argentina Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 South Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 South Africa Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 UAE Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 UAE Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 93 UAE Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Sustained Release Excipients Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Sustained Release Excipients Market: by Product Movement Analysis
  • Fig. 16 Global Sustained Release Excipients Market, for Gelatin, 2018 - 2030 (USD Million)
  • Fig. 17 Global Sustained Release Excipients Market, for Polymers, 2018 - 2030 (USD Million)
  • Fig. 18 Global Sustained Release Excipients Market, for Minerals, 2018 - 2030 (USD Million)
  • Fig. 19 Global Sustained Release Excipients Market, for Sugars, 2018 - 2030 (USD Million)
  • Fig. 20 Global Sustained Release Excipients Market, for Alcohol, 2018 - 2030 (USD Million)
  • Fig. 21 Global Sustained Release Excipients Market, for Chitosan, 2018 - 2030 (USD Million)
  • Fig. 22 Global Sustained Release Excipients Market: Technology Movement Analysis
  • Fig. 23 Global Sustained Release Excipients Market, for Targeted Delivery, 2018 - 2030 (USD Million)
  • Fig. 24 Global Sustained Release Excipients Market, for Micro Encapsulation, 2018 - 2030 (USD Million)
  • Fig. 25 Global Sustained Release Excipients Market, for Wurster Technique, 2018 - 2030 (USD Million)
  • Fig. 26 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
  • Fig. 27 Global Sustained Release Excipients Market, for Implants, 2018 - 2030 (USD Million)
  • Fig. 28 Global Sustained Release Excipients Market, for Coacervation, 2018 - 2030 (USD Million)
  • Fig. 29 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Sustained Release Excipients Market: Route of Administration Movement Analysis
  • Fig. 31 Global Sustained Release Excipients Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 32 Global Sustained Release Excipients Market, for Intramuscular, 2018 - 2030 (USD Million)
  • Fig. 33 Global Sustained Release Excipients Market, for Subcutaneous, 2018 - 2030 (USD Million)
  • Fig. 34 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
  • Fig. 35 Global Sustained Release Excipients Market, for Vaginal, 2018 - 2030 (USD Million)
  • Fig. 36 Global Sustained Release Excipients Market, for Ophthalmic, 2018 - 2030 (USD Million)
  • Fig. 37 Global Sustained Release Excipients Market, for Intravenous, 2018 - 2030 (USD Million)
  • Fig. 38 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Sustained Release Excipients Market :Regional Outlook, 2022 & 2030, 2018 - 2030 (USD Million)
  • Fig. 40 North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait Sustained Release Excipients Market, 2018 - 2030 (USD Million)